Petrylak, MD, of the Yale School of Medicine notes that bone health is a frequently underappreciated aspect of care for ...

Dr. Bertrand Tombal delivered a practical presentation titled “What Do You Need for Decision Making in mHSPC in 2026?”, ...

Cardiovascular disease is the second leading cause of death among cancer survivors, second only to cancer itself. The same treatments that can save patients from cancer may also r ...

Dr. Fizazi began by revisiting the role of docetaxel in the mHSPC setting, emphasizing that treatment benefit varies ...

A Brit has become the first patient in Europe to trial a pioneering antibody drug that ‘attaches’ to cancer cells. Brian Holmes, 70, has suffered with metastatic prostate cancer for two years and has ...

UK cancer death rates have fallen to a record low after decades of progress, yet deaths from skin, liver and other cancers ...

A new international study has found that combining two cancer medicines may significantly slow the growth of a dangerous form ...

A former Rosyth dockyard worker has revealed the 'horrendous' experience of his prostate cancer to encourage men to get tested. Alex Keatings, 68, who worked for decades as a manager for the aircraft ...

Daffodil Day is set to take place this Friday, March 20 and will fundraise to support cancer patients and their families ...

The milestone reinforces NBT’s position as one of the UK’s leading centres for robotic surgery and aligns closely with ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...